Jinyu Bio-Technology Co

Jinyu Bio-Technology Co Current Liabilities

The Current Liabilities of Jinyu Bio-Technology Co (600201.SS) as of Oct 27, 2026 is 263.56 M CNY. In the previous year, Current Liabilities was 777.28 M CNY — a change of -66.09% (lower).

Current Liabilities

263.56 MCNY

YoY

-66.09%

Last updated:

Current Liabilities of Jinyu Bio-Technology Co is 2025 263.56 M CNY. Current Liabilities of Jinyu Bio-Technology Co was 2024 777.28 M CNY. It decreases by -66.09% lower compared to the previous year.

The Jinyu Bio-Technology Co Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
968.11 M CNY
Jan 1, 2019
630.03 M CNY
Jan 1, 2020
740.75 M CNY
Jan 1, 2021
669.89 M CNY
Jan 1, 2022
709.69 M CNY
Jan 1, 2023
903.35 M CNY
Jan 1, 2024
777.28 M CNY
Jan 1, 2025
263.56 M CNY
The Jinyu Bio-Technology Co Current Liabilities history
YEARCurrent LiabilitiesYoY
263.56 MCNY-66.09%
777.28 MCNY-13.96%
903.35 MCNY+27.29%
709.69 MCNY+5.94%
669.89 MCNY-9.57%
740.75 MCNY+17.57%
630.03 MCNY-34.92%
968.11 MCNY-12.77%
1.11 BCNY+104.94%
541.54 MCNY+14.32%
473.71 MCNY-2.45%
485.60 MCNY+1.47%
478.55 MCNY-39.26%
787.90 MCNY+0.79%
781.73 MCNY-5.11%
823.84 MCNY+20.61%
683.08 MCNY+24.35%
549.32 MCNY-8.44%
599.94 MCNY+45.75%
411.62 MCNY-32.01%
605.41 MCNY+69.20%
357.81 MCNY-6.73%
383.62 MCNY+37.05%
279.92 MCNY+5.81%
264.56 MCNY-7.39%
285.67 MCNY+92.84%
148.14 MCNY+31.31%
112.82 MCNY+7.51%
104.94 MCNY-11.06%
117.99 MCNY-10.10%
131.24 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jinyu Bio-Technology Co Stock analysis

What does Jinyu Bio-Technology Co do? Jinyu Bio-Technology Co., Ltd. generates revenue by researching, developing, producing, and selling veterinary biological products, with a primary focus on veterinary vaccines. The company operates from its headquarters in Hohhot, Neimenggu, where it employs 1,618 full-time staff members to support these core activities. In addition to its main veterinary operations, the firm diversifies its income streams by engaging in textile processing, providing energy products, and offering property leasing and management activities. These supplementary services allow the company to serve various market segments beyond the veterinary sector. The business model relies on the direct sale of its veterinary vaccines and biological products to customers in the animal health industry. By integrating manufacturing with research and development, Jinyu Bio-Technology Co., Ltd. maintains control over its product quality and supply chain while expanding into related industrial and service areas. Jinyu Bio-Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jinyu Bio-Technology Co stock

Current Liabilities of Jinyu Bio-Technology Co is 263.56 M CNY in 2025.

Current Liabilities of Jinyu Bio-Technology Co changed from 777.28 M CNY to 263.56 M CNY, representing a -66.09% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Jinyu Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Jinyu Bio-Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Jinyu Bio-Technology Co

All Key Metrics — Jinyu Bio-Technology Co